Senators Scrutinize US FDA Commissioner Nominee Makary Over VRBPAC Cancellation

 
• By Sue Sutter

Martin Makary said he would re-evaluate the topics that deserve a Vaccines and Related Biological Products Advisory Committee review, but did not commit to rescheduling the cancelled meeting on influenza vaccine strain selection.

Martin Makary Senate Confirmation Hearing
FDA Commissioner nominee Martin Makary faced questions about a cancelled vaccines advisory committee meeting during his confirmation hearing. (Screenshot of Senate Broadcast)

More from US FDA

More from Vaccines